Zynerba Pharmaceuticals to Present at Canaccord Genuity’s 36th Annual Growth Conference
DEVON, Pa., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the …